Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China

Lignende værker

• Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
  af: Ren, Maodong, et al.
  Udgivet: (2020)
• Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
  af: Tiffany Woo, et al.
  Udgivet: (2013-12-01)
• Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
  af: Marie T. Aouad, et al.
  Udgivet: (2017-04-01)
• Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
  af: Thomas Ledowski, et al.
  Udgivet: (2013-01-01)
• Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
  af: Hristovska, Ana‐Marija, et al.
  Udgivet: (2017)